Oita University, Japan
Mitsuru ISHIBAI is a student in PhD course of Oita university in Japan. He is interested in the contents of immunogenicity assessment of antibody drug during the review process of new drug application in Japan and evaluated whether or not ADA production, its impact on PK, efficacy, and/or safety were discussed in their review report. He is also a part of clinical pharmacology department in Eli Lilly Japan.